Quantifying crowding-ventilation effect on respiratory infections.

Publication date: May 21, 2026

Crowded and poorly ventilated indoor spaces drive outbreaks of respiratory infections such as coronavirus disease 2019 (COVID-19), often leading to superspreading events. While overcrowding heightens risk, its interplay with space size and ventilation remains underexplored. We introduce a framework to assess this risk, using effective clean flow rate, which combines clean airflow (outdoor air, filtration, ultraviolet germicidal irradiation) with volume-time air clearance (VTAC), i. e., dilution from indoor air volume per person over time, and intake fraction time, which quantifies aerosol exposure risk independent of infectious quanta generation. Analysis of real outbreak data from jails, earthquake shelters, and dormitories shows modest spaciousness (16-32 m/person) increases effective clean flow by 8. 7 to 17. 6 L/s per person in low-ventilation settings (0. 5 L/s per person, 1-hour exposure), reducing exposure. Current standards, such as American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) 62. 1-2022, fall short in crowded spaces, heightening infection risks. Our model predicts infection patterns, showing VTAC is a critical yet overlooked factor in limiting long-range airborne transmission. These insights call for updated ventilation and spaciousness standards to strengthen public health strategies.

Open Access PDF

Concepts Keywords
Coronavirus Air
Dormitories Clean
Earthquake Crowded
Overcrowding Effective
Exposure
Flow
Indoor
Infections
Person
Respiratory
Risk
Spaces
Time
Ventilation
Volume

Semantics

Type Source Name
disease MESH respiratory infections
disease MESH coronavirus disease 2019
drug DRUGBANK Medical air
disease MESH infection
pathway REACTOME Reproduction
disease MESH included
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH influenza
disease MESH severe acute respiratory syndrome
drug DRUGBANK Carbon dioxide
drug DRUGBANK Isoxaflutole
drug DRUGBANK Acetylcholine
disease MESH ACH
drug DRUGBANK Methionine
disease MESH secondary infections
disease MESH common colds
disease MESH emergency

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *